Search results
STI Treatment Guidelines from CDC. As CDC and others work quickly to evaluate data to inform clinical guidance on the safe and effective use of post-exposure prophylaxis with doxycycline (also called doxy as PEP) to prevent gonorrhea, chlamydia, and syphilis, we acknowledge there are individuals and clinicians who are already engaged in the off-label use of doxycycline as bacterial STI post ...
Jul 23, 2021 · Use of acyclovir had no effect on HIV transmission. These findings are consistent with a previous trial that reported no benefit of acyclovir in preventing HIV acquisition among persons seropositive for HSV-2 (89). Doxycycline prophylaxis has been examined for preventing bacterial STIs.
- Kimberly A Workowski, Laura H Bachmann, Philip A Chan, Christine M Johnston, Christina A Muzny, Ina ...
- 2021
Guidelines for the Use of Doxycycline Post-Exposure Prophylaxis for Bacterial STI Prevention. Print. Efficacy of Doxycycline as PEP to Prevent Bacterial STIs. Doxycycline Individual Level Harms – Antimicrobial Resistance. Doxycycline Use and Adverse Events. Last Reviewed: September 29, 2023.
Feb 27, 2020 · Questions concerning doxycycline use in young children may arise in relation to treatment of infection by Borrelia burgdorferi sensu lato. Several antimicrobial agents offer efficacy in the treatment of Lyme disease in children: amoxicillin, cefuroxime axetil, ceftriaxone and doxycycline.
Doxycycline, 100 mg orally twice a day for 7 days (add ceftriaxone, 500 mg intramuscularly, for gonococcal coverage if high risk or high prevalence area) Chlamydial...
Jul 22, 2021 · Gonococcal Infections Among Adolescents and Adults. Gonococcal Infections Among Neonates. Gonococcal Infections Among Infants and Children. Next. Page last reviewed: July 22, 2021. Content source: Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention. STI ...
Jul 23, 2021 · Studies have shown doxycycline is more efficacious than azithromycin, especially for extragenital sites. If doxycycline non-adherence is a concern, azithromycin is an option. If azithromycin is used, post-treatment evaluation and testing should be considered, especially with rectal infections. Gonorrhea.
